Abstract
608 Myelodysplastic Syndromes in Adolescent Young Adults e The Moffitt Experience Joanna Grabska, Bijal Shah, Najla Al Ali, Eric Padron, Hanadi Ramadan, Jeffrey Lancet, Alan List, Rami Komrokji Moffitt Cancer Center, Tampa, FL, USA Introduction: There has been little improvement in cancer survival of adolescent and young adult (AYA) patients, ages 18-39, possibly reflecting different disease biology. Myelodysplastic syndrome (MDS) is mainly a disease of the elderly. The characteristics, outcomes and response to treatment are not well described in AYA population. Patients and Methods: Retrospective review Table 1 Characteristics of AYA and Older Patients Characteristic AYA (18-39) N[ 51 O
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
